Corteva (NYSE:CTVA) Stock Sold by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Corteva, Inc. (NYSE:CTVA). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Corteva stock on September 17th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Corteva Stock Up 0.2%

Shares of NYSE:CTVA opened at $13.33 on Wednesday. The company has a market capitalization of $8.89 billion, a price-to-earnings ratio of 8.83, a P/E/G ratio of 1.86 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The business’s 50-day moving average is $68.92 and its 200-day moving average is $77.33. Corteva, Inc. has a 1 year low of $11.74 and a 1 year high of $90.97.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The company had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the prior year, the company earned $2.20 EPS. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts predict that Corteva, Inc. will post 1.04 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 5.4%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Hedge Funds Weigh In On Corteva

A number of institutional investors have recently modified their holdings of CTVA. Wellington Management Group LLP grew its position in Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after buying an additional 6,881,875 shares during the period. Rakuten Investment Management Inc. bought a new position in shares of Corteva during the 2nd quarter valued at approximately $9,132,000. Kingsview Wealth Management LLC purchased a new stake in shares of Corteva during the 2nd quarter worth approximately $1,093,000. Jupiter Topco LLC purchased a new stake in shares of Corteva during the 2nd quarter worth approximately $544,246,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Corteva in the 2nd quarter worth approximately $392,447,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. New Street Research set a $17.00 price target on Corteva in a report on Monday, October 5th. BMO Capital Markets set a $15.00 price objective on shares of Corteva in a report on Friday, October 2nd. Citigroup upped their price objective on shares of Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a report on Thursday, September 17th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. Finally, Bank of America raised their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and an average price target of $60.59.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.